After a two month long investigation, an Overview Committee compiled by the University concluded that “allegations of substandard care causing adverse outcomes for patients at the Center are unsubstantiated,” as written in a public summary of conclusions. 

Washington University completed an internal review of the Washington University Transgender Center (the Center) on April 21. 

The University’s review was conducted after Jamie Reed, a former case manager at the Center, claimed malpractice in an article published by The Free Press in early February. Attorney General Andrew Bailey launched an investigation of the Center shortly after the article’s release. A brief published by The Source said that the University is continuing to cooperate with the state’s evaluation. 

Julie Flory, the vice chancellor for marketing and communications, declined to comment on either the Attorney General’s investigation or how members were chosen for the Overview Committee, stating that the University did not have any further information to share. 

According to the summary of conclusions, over the last 58 months, 1,165 patients have sought care at the Center. Those patients have accumulated a total of 6,000 visits, ranging from telephone consultations to in-person care. The Center has performed six top surgeries, though the report states that “Washington University physicians no longer perform gender-affirming surgeries on patients under the age of 18.”

Through interviews with employees and combing patient records, the University found no evidence of patients having adverse reactions to medications prescribed by the Center physicians. The Committee also reported that “Mental health care and counseling is a priority at the Center,” and mental health assessments were provided for all patients under 18. 

Additionally, the Committee found that all patients under 18 had documented and verbal parental consent for care they received at the Center. In a section marked “Recommendations” at the end of the report, the Committee suggested that the Center revise their policy to require written records of consent before physicians prescribed gender-affirming medication to minors.